CTTC owns equity in a diverse group of companies that span a range of technologies and industries including assistive exosuits, online education, computerized surgical navigation, nanotechnology, personalized medicine, clinical information management systems, clinical diagnostics, drug discovery, radiation therapy, and healthcare services. The Center’s active portfolio currently includes the following companies:
AbSeek BioProviding Ab discovery, vaccine testing, and optimization services.
Innovative solutions to address unmet needs in diabetes care
American Sentinel University
Biopharmaceutical Drug Development Company with Innovative Peptide-based Solutions for Inflammation and Metabolic Syndrome
Appello Pharmaceuticals, Inc.
Focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease.
Cumberland Emerging Technologies
Life sciences business incubation
eFiber InnovationsWe manufacture nanofiber-based materials/devices that: (1) address critical needs, (2) exhibit unparalleled performance/durability and (3) are available commercially at a competitive cost.
Frontier DiagnosticsDiagnosing cancerous growths can be difficult for even the most experienced pathologist. Utilizing the cutting edge Imaging Mass Spectrometry technology, MelanoMap works to give the pathologists the most accurate information so that they can make the correct diagnosis.
Enables the application of genomics in oncology to improve patient care
HeroWear is designing a line of wearable technology that improves the safety, health, and productivity of workers in physically demanding jobs. Our first product is a lift assistance device that fits like clothing, while significantly offloading the low back muscles.
Discovery and development of human monoclonal antibodies for the prevention, treatment, and cure of infectious diseases.
Informatics Corporation of America
Clinical IT systems
International FemtoScience, Inc.
Research & development for advanced technology
CQI software and services
Meru BiotechnologiesMeru Biotechnologies’ Free Solution Analysis (FSA)combines the strengths of existing label-free approaches in a straightforward analytical platform, powered by advancements in Compensated Interferometry, which uses a single laser to measure experimental and reference samples in the same microfluidic channel simultaneously.
MetalyticsMetalytics provides critical information about cellular metabolic rates in living cells, giving our clients actionable results they can implement to accelerate research, development, and manufacturing timelines.
Nashville BiosciencesLeveraging real-world clinical and genomic data to advance the discovery and development of new, more personalized therapeutics and diagnostics.
nPhaseMachine to machine wireless communications and services for healthcare, manufacturing, utilities, distribution, and consumer product industries.
Path Ex, Inc.
PATH EX is an extracorporeal blood cleansing device designed to selectively remove bacteria, including multi-drug resistant strains, and endotoxin from circulating blood.
Drug delivery system
ProtypiaProtypia analyzes the protein targets of oncology drugs and the protein pathways and networks in which they function. We use new mass spectrometry technology to quantitatively and precisely measure proteins.
SkyNano TechnologiesWe focus on a low cost manufacturing technique of high value carbon materials, using only inexpensive materials, electricity, and carbon dioxide as direct inputs.
SynchromotionSynchro Motion’s vision is to become established as an industry leader in the design and control of rehabilitation robotics.
Natural insect control products
Unify PharmaceuticalsUnify Pharmaceuticals is a biotech company utilizing the latest scientific discoveries to develop drugs targeting neurodegenerative diseases such as Parkinson’s Disease, Myocardial Infarction, Macular Degeneration, Alzheimer’s and Strokes.
Hardware-independent software engineering company specializing in machine learning
Transforming minimally invasive surgery by providing surgeons with dexterous, accurate, and cost-effective robotic tools through endoscopes.
Developing a low-cost, non-invasive device that measures fluid status
Drug Discovery Tools